Synthesis of Novel Isoindolinones: Carbonic Anhydrase Inhibition Profiles, Antioxidant Potential, Antimicrobial Effect, Cytotoxicity and Anticancer Activity
Journal of Biochemical and Molecular Toxicology · 2025-04 · 39 (4)
DOI: 10.1002/jbt.70261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 14.04.2025. Verfasst von Yusuf Serdar Yazıcıoğlu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Sciences, Atatürk University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Antineoplastic Agents, Antioxidants, Isoindoles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Arastirma Kurumu..
Abstract (Originalsprache)
An efficient one‐pot method has been developed for synthesizing novel isoindolinone derivatives from 2‐benzoylbenzoic acid using chlorosulfonyl isocyanate and alcohols. This reaction occurs under mild, metal‐free conditions, rendering it a sustainable and effective approach for isoindolinone synthesis. The inhibitory potential of the synthesized compounds against human carbonic anhydrase (hCA) I and II isozymes was evaluated and compared with the standard inhibitor, acetazolamide (AAZ). Additionally, their antimicrobial and antioxidant activities were assessed using various bioanalytical methods, with results benchmarked against standard reference compounds. Furthermore, cytotoxicity and anticancer activity were investigated in L929 and A549 cell lines via the WST‐1 assay following a 24 h exposure. Among the synthesized derivatives, compounds 2c and 2f exhibited superior inhibitory effects on hCA I and II compared to AAZ, with Ki values ranging from 11.48 ± 4.18 to 16.09 ± 4.14 nM for hCA I and 9.32 ± 2.35 to 14.87 ± 3.25 nM for hCA II. These findings indicate that compounds 2c and 2f have a high affinity for the enzyme's active site, resulting in more effective inhibition of its catalytic activity. Compound 2e emerged as the most promising candidate, demonstrating potent carbonic anhydrase inhibition and significant antioxidant and antimicrobial properties. None of the synthesized compounds displayed cytotoxic effects on healthy cells at the tested concentrations. Additionally, compound 2a exhibited dose‐dependent anticancer activity against A549 cells. These results suggest that isoindolinone derivatives, particularly 2f , hold substantial potential for further pharmaceutical development as multifunctional bioactive agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Sciences, Atatürk University, Erzurum, Turkey.
- Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, Turkey.
Förderung
- Türkiye Bilimsel ve Teknolojik Arastirma Kurumu.
Zitieren
APA
Yazıcıoğlu, Y. S., Elmas, Ş., Kılıç, Z., Çelik, M., Bakan, B., Atmaca, U., & Bayrak, S. (2025). Synthesis of Novel Isoindolinones: Carbonic Anhydrase Inhibition Profiles, Antioxidant Potential, Antimicrobial Effect, Cytotoxicity and Anticancer Activity. Journal of Biochemical and Molecular Toxicology, 39(4). https://doi.org/10.1002/jbt.70261
Vancouver
Yazıcıoğlu YS, Elmas Ş, Kılıç Z, Çelik M, Bakan B, Atmaca U, et al. Synthesis of Novel Isoindolinones: Carbonic Anhydrase Inhibition Profiles, Antioxidant Potential, Antimicrobial Effect, Cytotoxicity and Anticancer Activity. Journal of Biochemical and Molecular Toxicology. 2025;39(4). doi:10.1002/jbt.70261
BibTeX
@article{Yazcolu2025,
author = {Yazıcıoğlu, Yusuf Serdar and Elmas, Şeydanur and Kılıç, Zeynep and Çelik, Murat and Bakan, Buket and Atmaca, Ufuk and Bayrak, Songül},
title = {Synthesis of Novel Isoindolinones: Carbonic Anhydrase Inhibition Profiles, Antioxidant Potential, Antimicrobial Effect, Cytotoxicity and Anticancer Activity},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {4},
doi = {10.1002/jbt.70261}
}
EUVIMED